IRLAB Therapeutics (Sweden) Market Value
| IRLAB-A Stock | SEK 3.39 0.04 1.19% |
| Symbol | IRLAB |
IRLAB Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IRLAB Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IRLAB Therapeutics.
| 04/22/2025 |
| 07/21/2025 |
If you would invest 0.00 in IRLAB Therapeutics on April 22, 2025 and sell it all today you would earn a total of 0.00 from holding IRLAB Therapeutics AB or generate 0.0% return on investment in IRLAB Therapeutics over 90 days. IRLAB Therapeutics is related to or competes with Sprint Bioscience, Intervacc, Fluicell, Galecto, Bicycle Therapeutics, Cantargia, and Vicore Pharma. IRLAB Therapeutics AB operates as a drug discovery and development company that provides drugs in the field of neurologi... More
IRLAB Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IRLAB Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess IRLAB Therapeutics AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 49.91 | |||
| Value At Risk | (4.56) | |||
| Potential Upside | 4.7 |
IRLAB Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IRLAB Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IRLAB Therapeutics' standard deviation. In reality, there are many statistical measures that can use IRLAB Therapeutics historical prices to predict the future IRLAB Therapeutics' volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.88) | |||
| Total Risk Alpha | (1.73) | |||
| Treynor Ratio | 2.32 |
IRLAB Therapeutics Backtested Returns
IRLAB Therapeutics holds Efficiency (Sharpe) Ratio of -0.16, which attests that the entity had a -0.16 % return per unit of risk over the last 3 months. IRLAB Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out IRLAB Therapeutics' Coefficient Of Variation of (621.31), market risk adjusted performance of 2.33, and Risk Adjusted Performance of (0.14) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.4, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning IRLAB Therapeutics are expected to decrease at a much lower rate. During the bear market, IRLAB Therapeutics is likely to outperform the market. At this point, IRLAB Therapeutics has a negative expected return of -0.92%. Please make sure to check out IRLAB Therapeutics' total risk alpha, skewness, rate of daily change, as well as the relationship between the maximum drawdown and accumulation distribution , to decide if IRLAB Therapeutics performance from the past will be repeated at future time.
Auto-correlation | -0.7 |
Very good reverse predictability
IRLAB Therapeutics AB has very good reverse predictability. Overlapping area represents the amount of predictability between IRLAB Therapeutics time series from 22nd of April 2025 to 6th of June 2025 and 6th of June 2025 to 21st of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of IRLAB Therapeutics price movement. The serial correlation of -0.7 indicates that around 70.0% of current IRLAB Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.7 | |
| Spearman Rank Test | -0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 2.43 |
IRLAB Therapeutics lagged returns against current returns
Autocorrelation, which is IRLAB Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting IRLAB Therapeutics' stock expected returns. We can calculate the autocorrelation of IRLAB Therapeutics returns to help us make a trade decision. For example, suppose you find that IRLAB Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
IRLAB Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If IRLAB Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if IRLAB Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in IRLAB Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
IRLAB Therapeutics Lagged Returns
When evaluating IRLAB Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of IRLAB Therapeutics stock have on its future price. IRLAB Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, IRLAB Therapeutics autocorrelation shows the relationship between IRLAB Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in IRLAB Therapeutics AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in IRLAB Stock
IRLAB Therapeutics financial ratios help investors to determine whether IRLAB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IRLAB with respect to the benefits of owning IRLAB Therapeutics security.